-
2020-07-31
b936bfee1ec79d4049fcb8e81eb1495ace1f0f55
30
COVID-19 pandemic
1
/wiki/covid-19%20pandemic
COVID-19 vaccine
71
/wiki/covid-19%20vaccine
GSK
37
/wiki/glaxosmithkline
Sanofi
14
/wiki/sanofi
federal
2
/wiki/federal%20government%20of%20the%20united%20states
COVID-19 pandemic
COVID-19 vaccine
GSK
Sanofi
federal
COVID-19 pandemic
2021-12-9
c5b6a1a7e9d76989f6263e46f4a05b7bc4991ad0
17
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/12/9/the-centers-for-disease-control-and-prevention-recommends-that-people-as-young-as-16-years-receive-a-booster-dose-of-the
The Centers for Disease Control and Prevention recommends that people as young as 16 years receive a booster dose of the COVID-19 vaccine. This comes after the FDA authorized the usage of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for people in that age group.
2021-06-22
1bce4131e7b76a53e62c21e912ae5244466b1957
/feed/2021/06/22/prime-minister-mario-draghi-receives-his-second-dose-of-the-covid-19-vaccine-however-draghi-received-the-pfizer-bionte
Prime Minister Mario Draghi receives his second dose of the COVID-19 vaccine. However, Draghi received the Pfizer–BioNTech vaccine for his second dose instead of the AstraZeneca vaccine.
1699928630
2021-06-22
b95fe59a411f514f0fb6f0f9602b01b0a653ab47
11
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/06/22/chancellor-angela-merkel-receives-her-second-dose-of-the-covid-19-vaccine-however-merkel-received-the-moderna-vaccine
Chancellor Angela Merkel receives her second dose of the COVID-19 vaccine. However, Merkel received the Moderna vaccine for her second dose rather than the AstraZeneca vaccine.
2021-06-2
fb948e212666dabe929d1e25c89b6e711138cb61
17
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/06/2/mauritius-approves-the-usage-of-the-single-dose-sputnik-light-vaccine
Mauritius approves the usage of the single-dose Sputnik Light vaccine.
2021-05-11
31493e6c43be71cfa85006a3898118f384d8b395
/feed/2021/05/11/spain-approves-the-use-of-the-johnson-johnson-vaccine-for-people-under-the-age-of-60
Spain approves the use of the Johnson & Johnson vaccine for people under the age of 60.
1620803182
2021-05-11
d5d4001bc2061049ec81db125a95634e925498de
/feed/2021/05/11/spain-approves-the-use-of-the-johnson-johnson-vaccine-for-people-under-the-age-of-60-https-elpaiscom-sociedad-202
Spain approves the use of the Johnson & Johnson vaccine for people under the age of 60. [https:--elpais.com-sociedad-2021-05-11-sanidad-y-comunidades-debaten-esta-tarde-autorizar-la-vacuna-monodosis-de-janssen-para-menores-de-60-anos.html ("El Pais")]\
1620795954
2021-05-11
64f4f911881106397caea86a39a8eedda2ceac95
/feed/2021/05/11/spain-approves-the-use-of-the-johnson-johnson-vaccine-for-people-aged-under-60-years-old
Spain approves the use of the Johnson & Johnson vaccine for people aged under 60 years old.
1620778841
2021-05-11
ecafe1e91a44f823a61252e1eb021c07d0a4c373
20
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/05/11/spain-approves-the-use-of-the-johnson-johnson-vaccine-for-people-under-the-age-of-60-years
Spain approves the use of the Johnson & Johnson vaccine for people under the age of 60 years.
2021-04-20
bbe9ae9661440ce18c8aac05616c753a4f09f25c
24
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/04/20/egypt-signs-an-agreement-to-purchase-20-million-doses-of-the-sinopharm-bbibp-corv-vaccine-and-expects-a-delivery-of-500
Egypt signs an agreement to purchase 20 million doses of the Sinopharm BBIBP-CorV vaccine and expects a delivery of 500,000 doses this month.
2021-04-6
407aa880f10d0d36e7ef6d31cbb3de4d3d0f397b
/feed/2021/04/6/indonesia-reports-their-first-case-of-a-more-transmissible-new-variant-of-the-sars-cov-2-nicknamed-eek-which-contains
Indonesia reports their first case of a more transmissible new variant of the SARS-CoV-2 nicknamed "Eek", which contains the E484K mutation that can reduce vaccine protection.
1617980733
2021-04-6
b2197bf4206cc0d3c8cb21aa84dfcd762cf1e537
/feed/2021/04/6/indonesia-reports-the-first-case-of-a-more-transmissible-new-variant-of-the-sars-cov-2-nicknamed-as-eek-which-contain
Indonesia reports the first case of a more transmissible new variant of the SARS-CoV-2 nicknamed as "Eek", which contains the E484K mutation that can reduce the vaccine protection.
1617757544
2021-04-6
7ae621360b82fee61da4be0adff6015757e646eb
28
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2021/04/6/indonesia-reports-its-first-case-of-a-more-transmissible-new-variant-of-the-sars-cov-2-nicknamed-eek-which-contains-t
Indonesia reports its first case of a more transmissible new variant of the SARS-CoV-2 nicknamed "Eek", which contains the E484K mutation that can reduce vaccine protection.
2021-02-22
bafbb7f746dcccb98626fc441ea586a87868d750
47
COVID-19 pandemic
COVID-19 vaccine
GSK
Sanofi
4
/feed/2021/02/22/glaxosmithkline-and-sanofi-begins-new-clinical-trial-of-their-protein-based-vaccine-candidate-and-aim-to-reach-the-final
GlaxoSmithKline and Sanofi begins new clinical trial of their protein-based vaccine candidate and aim to reach the final testing stage in the second quarter after setback last year.
2020-12-11
f76eec2621547d95a770d7db94be2f0f48da473f
/feed/2020/12/11/sanofi-and-glaxosmithkline-announce-that-their-vaccine-candidate-will-not-be-ready-until-the-end-of-2021
Sanofi and GlaxoSmithKline announce that their vaccine candidate will not be ready until the end of 2021.
1607778266
2020-12-11
e1749be90459de91f36cbce7fe489253484cba01
42
COVID-19 pandemic
GSK
Sanofi
3
/feed/2020/12/11/sanofi-and-glaxosmithkline-announce-that-their-covid-19-vaccine-candidate-will-not-be-ready-until-the-end-of-2021
Sanofi and GlaxoSmithKline announce that their COVID-19 vaccine candidate will not be ready until the end of 2021.
2020-12-5
079c84b3744f01215f4b0b82ec57d6e15a014eb9
/feed/2020/12/5/moscow-begins-to-vaccinate-high-risk-workers-with-the-sputnik-v-vaccine-at-70-newly-opened-clinics-across-the-city-mark
Moscow begins to vaccinate high-risk workers with the Sputnik V vaccine at 70 newly opened clinics across the city, marking Russia’s first mass COVID-19 vaccination.
1662339854
2020-12-5
d7f0a7cde33bb910245e38bdb6c383690fd7a885
/feed/2020/12/5/moscow-begins-to-vaccinate-high-risk-workers-at-newly-opened-clinics-across-the-city-as-it-distributed-the-sputnik-v-sho
Moscow begins to vaccinate high-risk workers at newly opened clinics across the city as it distributed the Sputnik V shot via 70 clinics, marking Russia’s first mass vaccination against COVID-19.
1607216677
2020-12-5
1282e4d2f293c002bf688e547326153bc0361614
23
COVID-19 pandemic
COVID-19 vaccine
2
/feed/2020/12/5/moscow-begins-to-vaccinate-high-risk-workers-with-the-sputnik-v-covid-19-vaccine-at-70-newly-opened-clinics-across-the-c
Moscow begins to vaccinate high-risk workers with the Sputnik V COVID-19 vaccine at 70 newly opened clinics across the city, marking Russia’s first mass COVID-19 vaccination.
2020-09-3
8b04fb79eb83ea9fd0e6465bedc5dcd1ff21eef1
22
COVID-19 pandemic
GSK
Sanofi
3
/feed/2020/09/3/glaxosmithkline-and-sanofi-announces-that-they-will-start-vaccine-trials
GlaxoSmithKline and Sanofi announces that they will start vaccine trials.
/feed/2020/07/31/the-united-states-government-is-expected-to-pay-21-billion-to-sanofi-and-glaxosmithkline-to-try-to-develop-and-deliver
CNBC
31
b80e05734d64e3196a06161e645da774d07c5ae2
7
https://www.cnbc.com/2020/07/31/us-agrees-to-pay-sanofi-and-gsk-2point1-billion-for-100-million-doses-of-coronavirus-vaccine.html
2020
The United States government is expected to pay $2.1 billion to Sanofi and GlaxoSmithKline to try to develop and deliver 100 million doses of their potential COVID-19 vaccine.